Michella IBRAHIM HAYEK (EL)

Chargé de Cours

Institute of Occupational Therapy

Institute of Psychomotor Therapy

+961 (1) 421 000 michella.ibrahim1@usj.edu.lb

Michella Ibrahim is a neurologist who graduated from Saint Joseph University of Beirut. She pursued six years of specialized training in France in the field of neuro-inflammatory and neuromuscular diseases, mainly at the Pitie-Salpetriere Hospital. Multi-degreed, she obtained several university diplomas as well as an MSc and an MPH awarded by Sorbonne University, Paris-Saclay University, and Clermont Auvergne University. Her expertise focuses on multiple sclerosis, neuromyology, and clinical research. She is a member of several international learned societies and regularly participates in scientific conferences, as a presenter or reviewer.

Education

Degree	University	Country	Year
Diplôme d'université - Myologie	Sorbonne Université	France	2024
M2 - Recherche biomédicale	Université Paris - Saclay	France	2022
Diplôme d'université - Neuro-ophtalmologie	Sorbonne Université	France	2021
Diplôme d'université - toxine botulique et pathologie du mouvement	Université d'Auvergne(Clermont-Ferrand I)	France	2021
M2 - science handicap neurologique	Université Paris - Saclay	France	2021
Diplôme de spécialisation - Neurologie	Université de Paris	France	2020
Diplôme de spécialisation - Neurologie	Université Saint-Joseph de Beyrouth	Liban	2020
Diplôme d'université - myéline et maladies de la substance blanche	Sorbonne Université	France	2020
Doctorat d'exercice - Médecine	Université Saint-Joseph de Beyrouth	Liban	2015

Publications and communications

EUROPEAN JOURNAL OF NEUROLOGY (Jun 2023) : Three to four mRNA COVID-19 vaccine in multiple sclerosis patients on immunosuppressive drugs: seroconversion and variants neutralization MULTIPLE SCLEROSIS AND RELATED DISORDERS (Mar 2022) : Health related quality of life and perceived social support in French and Lebanese MS patients: a comparative study JOURNAL OF NEUROLOGY, NEUROSURGERY, AND PSYCHIATRY (Aug 2021) : Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (Jul 2021) : DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France EPILEPSY AND BEHAVIOR REPORTS (Apr 2020) : Impact of epilepsy training on school teachers and counselors: an intervention study in Lebanon